Blog - Page 527 of 5683 - QualityStocks

ThursdayMar 21, 2024 12:33 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Financial Results, Corporate Highlights for Q4, FY 2023

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has announced its financial numbers and operational highlights for the fourth quarter and full year ended Dec. 31, 2023. According to the report, key achievements during the period included enrolling the first patients for a pivotal trial studying AIMIGo(TM) System for synthesizing a 12-lead ECG as well as clinical and regulatory progress made for the AIMIGo 3D VECG system. In addition, the company noted it had received two new patents during the period, covering HeartBeam’s proprietary technologies. “We have continued to make…

ThursdayMar 21, 2024 12:15 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Continuing to Redefine Logistics Landscape with Innovative Solutions

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company whose custom-developed, industry-leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has been Riisa’s trusted logistics supplier for over two years, facilitating cross-border exportations and enabling Riisa to move its products with ease and efficiency. In Fr8App’s continued focus on redefining the logistics landscape, it empowers businesses like Riisa with cutting-edge solutions that enhance operational efficiency and elevate the overall shipping experience. “Our Fr8App platform is the perfect tool for companies looking to optimize their cross-border logistics operations and reduce…

ThursdayMar 21, 2024 12:00 pm

Diamond Lake Minerals Inc. (DLMI) Announces Investment in Avrio Worldwide PBC Amidst Avrio’s Acquisition of HUMBL and SocialTrader

Diamond Lake Minerals purchased a 24% stake in Avrio Worldwide PBC in a strategic investment opportunity Avrio has partnered with HUMBL Financial to acquire the HUMBL Financial brand, products, and services Avrio also announced a 1:10 share exchange agreement, resulting in a bi-directional common stock acquisition between the company and SocialTrader.AI SocialTrader will deploy Avrio's digital financial market infrastructure to access public, private, and digital markets across multiple asset classes Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company on a path to emerging as a pioneering force in the development of digital assets and SEC-registered security tokens, recently announced…

ThursdayMar 21, 2024 11:15 am

Advanced Gold Exploration Inc. (CSE: AUEX) (OTC: AUHIF) (FSE: 4TG) Is ‘One to Watch’

Advanced Gold Exploration in January 2024 closed the first tranche of a non-brokered private placement for aggregate gross proceeds of $62,500 A continuing private placement is in progress and will be closed soon In December 2023, the company exercised its option to acquire a 75% interest in certain mineral claims located in Melba Township in the Kirkland Lake Area of Ontario In October 2023, Advanced Gold Exploration acquired an option on the Landrum gold property in South Carolina from Carolina Gold Resources The company announced in September 2023 it would change its corporate name to Advanced Gold Exploration Inc. Advanced…

ThursdayMar 21, 2024 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Developing Pipeline to Address Unmet Needs in Autism Spectrum Disorder via Suramin Sodium

Autism (“ASD”) is a global problem, with no generally accepted treatment. In the UK alone, between 1998 and 2018, research has found a greater than 780% increase in the number of autism cases PaxMedica is focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of ASD and other serious conditions with intractable neurologic symptoms The ASD therapeutics market was valued at $2.01 billion in 2023 and is expected to reach $3.42 billion by 2030, growing at a CAGR of 7.9% There is currently no approved pharmacologic treatment targeting the cause and symptoms. Current treatments only address the…

ThursdayMar 21, 2024 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Go-to-Market Growth Strategy and Upcoming Participation in 36th Annual Roth Conference

D-Wave’s new go-to-market (“GTM”) growth strategy, initially focused on key verticals, including logistics, manufacturing, and government, is expected to accelerate the adoption and deployment of commercial quantum technologies The GTM approach reinforces the value of the company’s unique annealing quantum computing solutions, which help organizations solve highly complex computational problems today According to Hyperion Research, over 80% of enterprises are expected to increase their investments in quantum computing over the next two to three years, with logistics and supply chain management identified as top sectors to benefit from quantum computing capabilities D-Wave Quantum (NYSE: QBTS), a leader in quantum computing…

ThursdayMar 21, 2024 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Achieves 7% Weight Loss; Sets Stage for 8-week Diabetes and Weight Loss Animal Study

Lexaria, a global innovator in drug delivery platforms, highlighted results from its DIAB-A22-1 animal study, highlighting a 7% reduction in weight and a 19.9% reduction in blood glucose With this success, Lexaria looks to kick off its WEIGHT-A24-1 animal study to examine diabetes and weight loss effects of its patented DehydraTECH(TM)-processed GLP-1 drugs and DehydraTECH-processed CBD The study will comprise 12 arms and involve 72 animals. It will run for a total of 12 weeks This study will build on previous studies that evidenced DehydraTECH’s potential to enable greater penetration of GLP-1 drugs into the brain tissue Lexaria Bioscience (NASDAQ:…

WednesdayMar 20, 2024 3:45 pm

QualityStocksNewsBreaks – Why Zoned Properties Inc. (ZDPY) Is ‘One to Watch’

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, is focused on acquiring value-add real estate within the U.S. regulated cannabis industry. “The company aspires to innovate, focusing on direct-to-consumer real estate that is leased to best-in-class cannabis retailers. The company is redefining the approach to commercial real estate investment through its standardized process backed by its proprietary property technology. Zoned Properties has developed a national ecosystem of real estate services to support its real estate development process, including a commercial real estate brokerage and a real estate advisory practice… The company targets commercial…

WednesdayMar 20, 2024 3:05 pm

QualityStocksNewsBreaks – GEMXX Corp. (GEMZ) Laying Foundation for Sustainable Long-Term Growth

GEMXX (OTC: GEMZ), a mining and jewelry-making company, specializes in the mining of ammolite, a rare, opal-like gemstone that is only found on the eastern slopes of the Rocky Mountains in Southern Alberta. Last year, the company expanded into the mining of gold to complement the historical resources that undergird its jewelry production strategy. “On Feb. 13, the company reported product deliveries worth $1,051,374 at retail for the month of January, highlighting the success of GEMXX’s focus on operational efficiency and production of high-margin products… GEMXX plans to build on the year-opening report with further investments in exploration, drilling, surveys,…

WednesdayMar 20, 2024 1:40 pm

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) on Promising Path to Meet Medical Needs of ASD Patients

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”), is focusing its lead program on autism spectrum disorder (“ASD”), for which there is no approved pharmacologic treatment targeting cause and symptoms. “The current ASD treatments only address the symptoms of the condition but do not target the pathophysiology itself. PaxMedica is on a promising path to address the unmet medical needs of families with ASD – bringing hope to millions,” a recent article reads. “PaxMedica is using existing research on a drug called suramin, initially created to treat a disease called Human African…

Site Search

Company Search